DAWNRAYS PHARMA 02348Hong Kong Stock Exchange

0.9600.00%( +0.000 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
DAWNRAYS PHARMA (02348) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2003-11-07
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG2687M1006

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)1.44B45/112
Net Profit (Last FY)250.92M39/125
ROE (Last FY)6.32%40/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
东瑞制药(控股)有限公司 Executive Director
李其玲 Executive Director
熊融礼 Executive Director
梁康民 Non-Executive Director
胡硕 Non-Executive Director
劳同声 Independent Non-Executive Director
EDE, Ronald Hao Xi Independent Non-Executive Director
林明仪 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-08-01.

About this page

This page shows DAWNRAYS PHARMA (02348) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.